爱尔兰白人人群血清GDF-15参考区间及在糖尿病肾病中的潜在应用
该横断面研究纳入188名健康志愿者和128名糖尿病患者(72例伴糖尿病肾病,56例不伴),用罗氏电化学发光免疫分析法测定血清GDF-15,建立参考区间为399-1335 ng/L,并初步评估其对糖尿病肾病的筛查价值。
要点
- 健康爱尔兰白人血清GDF-15参考区间为399-1335 ng/L。
- GDF-15诊断糖尿病肾病的ROC曲线下面积为0.931。
- 最佳切点>1136 ng/L,灵敏度94.4%、特异度79%。
核心结论
- 建立了健康爱尔兰白人血清GDF-15参考区间,并初步确定其作为糖尿病肾病筛查试验的潜力。
- 所提切点需在更大糖尿病肾病队列中前瞻性验证后方可用于临床。
研究设计与样本
- 横断面研究,纳入188名健康志愿者和128名糖尿病患者(72例伴糖尿病肾病,56例不伴)。
- 采用罗氏电化学发光免疫分析法测定血清GDF-15,参考区间取2.5th和97.5th百分位数。
主要发现
- 188名健康参与者中63名不符合纳入标准。
- 血清GDF-15参考区间为399 ng/L(90%CI:399-399)至1335 ng/L(90%CI:1152-1445)。
- 糖尿病肾病ROC曲线下面积为0.931(95%CI:0.893-0.959;p<0.001)。
- 预测糖尿病肾病的最佳GDF-15切点为>1136 ng/L,诊断灵敏度94.4%、特异度79%,阳性似然比4.5:1(95%CI:3.4-6.0)。
关键数值与推荐
- 参考区间下限399 ng/L(90%CI:399-399),上限1335 ng/L(90%CI:1152-1445)。
- 糖尿病肾病预测切点>1136 ng/L,灵敏度94.4%、特异度79%。
- 阳性似然比4.5:1(95%CI:3.4-6.0)。
临床怎么用
- 可参考该参考区间解读爱尔兰白人血清GDF-15结果。
- GDF-15切点>1136 ng/L可用于糖尿病肾病筛查的初步评估,但需进一步验证。
局限性
- 切点需在更大糖尿病肾病队列中前瞻性验证后方推荐临床使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Growth differentiation factor-15 (GDF-15), a stress responsive cytokine, is a promising biomarker of renal functional decline in diabetic kidney disease (DKD). This study aimed primarily to establish normative data and secondarily to evaluate the potential utility of GDF-15 in DKD using Roche Diagnostics electrochemiluminescence immunoassay (ECLIA) in an Irish Caucasian population. METHODS: Following informed consent, 188 healthy volunteers and 128 participants with diabetes (72 with and 56 without DKD) were recruited to a cross-sectional study. Baseline demographics, anthropometric measurements and laboratory measurements were recorded. Blood for GDF-15 measurement was collected into plain specimen tubes kept at room temperature and processed (centrifugation, separation of serum, freezing at -80 °C) within 1 h of phlebotomy pending batch analyses. Reference intervals were determined using the 2.5th and 97.5th percentiles for serum GDF-15 concentration. RESULTS: Of 188 healthy participants, 63 failed to meet study inclusion criteria. The reference interval for serum GDF-15 was 399 ng/L (90% confidence interval [CI]: 399-399) - 1335 ng/L (90% CI: 1152-1445). Receiver operator characteristics (ROC) curve analysis for DKD determined the area under the ROC curve to be 0.931 (95% CI: 0.893-0.959; p<0.001). The optimum GDF-15 cutoff for predicting DKD was >1136 ng/L providing a diagnostic sensitivity and specificity of 94.4% and 79%, respectively, and positive likelihood ratio of 4.5:1 (95% CI: 3.4-6.0). CONCLUSIONS: The reference interval for serum GDF-15 in a healthy Irish Caucasian population using Roche Diagnostics ECLIA was established and a preliminary determination of the potential of GDF-15 as a screening test for DKD was made. Further prospective validation with a larger DKD cohort will be required before the cutoff presented here is recommended for clinical use.
引用
- Hamon SM, Griffin TP, Islam MN, et al. Defining reference intervals for a serum growth differentiation factor-15 (GDF-15) assay in a Caucasian population and its potential utility in diabetic kidney disease (DKD). Clin Chem Lab Med. 2019. PMID: 30218600. doi:10.1515/cclm-2018-0534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。